「pr」の検索結果
229件：71～75件目を表示
-
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designatio...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
general image filing system by installing Logic and Design’s image sharpening algorithm. We aim to promote “more visibility” by providing products and services equipped with image sharpening and high...
https://www.senju.co.jp/system/files/content_news/2024-11/ENG_20241126.pdf -
bution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of s...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906_0.pdf -
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designatio...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has started Phase III c...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf